Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Apr;45(4):348–351. doi: 10.1136/jcp.45.4.348

Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

M Uguccioni 1, R Meliconi 1, E Lalli 1, S Nesci 1, C Delfini 1, G Lucarelli 1, G Gasbarrini 1, A Facchini 1
PMCID: PMC495278  PMID: 1577974

Abstract

AIMS: To investigate whether serum amyloid A protein (SAA) and C-reactive protein (CRP) concentrations could be used in the management of beta thalassaemic patients undergoing bone marrow transplantation (BMT). METHODS: Serum SAA and CRP concentrations were determined in paired samples from 66 patients with beta thalassaemia before and after BMT. Serum SAA concentrations were determined by an enzyme linked immunoassay (EIA); serum CRP concentrations were determined by a nephelometric assay. RESULTS: Serum SAA concentrations before transplantation were significantly higher in the group that subsequently rejected the transplant than the group without complications. SAA concentrations increased after BMT in acute graft versus host disease (GvHD) and rejection. No significant increase in SAA or CRP was found in chronic GvHD. Increases in serum in SAA and CRP concentrations were not related to concomitant infection episodes. CONCLUSIONS: The different acute phase response in acute GvHD and rejection compared with chronic GvHD suggests that different immunopathogenic mechanisms are responsible.

Full text

PDF
348

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbar A. N., Giardina P. J., Hilgartner M. W., Grady R. W. Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells. Clin Exp Immunol. 1985 Nov;62(2):397–404. [PMC free article] [PubMed] [Google Scholar]
  2. Benson M. D., Aldo-Benson M. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol. 1979 May;122(5):2077–2082. [PubMed] [Google Scholar]
  3. Ferrara J. L., Deeg H. J. Graft-versus-host disease. N Engl J Med. 1991 Mar 7;324(10):667–674. doi: 10.1056/NEJM199103073241005. [DOI] [PubMed] [Google Scholar]
  4. Ganapathi M. K., May L. T., Schultz D., Brabenec A., Weinstein J., Sehgal P. B., Kushner I. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun. 1988 Nov 30;157(1):271–277. doi: 10.1016/s0006-291x(88)80043-3. [DOI] [PubMed] [Google Scholar]
  5. Godenir N. L., Jeenah M. S., Coetzee G. A., Van der Westhuyzen D. R., Strachan A. F., De Beer F. C. Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum. J Immunol Methods. 1985 Nov 7;83(2):217–225. doi: 10.1016/0022-1759(85)90243-1. [DOI] [PubMed] [Google Scholar]
  6. Lucarelli G., Galimberti M., Polchi P., Angelucci E., Baronciani D., Giardini C., Politi P., Durazzi S. M., Muretto P., Albertini F. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990 Feb 15;322(7):417–421. doi: 10.1056/NEJM199002153220701. [DOI] [PubMed] [Google Scholar]
  7. Lucarelli G., Galimberti M., Polchi P., Giardini C., Politi P., Baronciani D., Angelucci E., Manenti F., Delfini C., Aureli G. Marrow transplantation in patients with advanced thalassemia. N Engl J Med. 1987 Apr 23;316(17):1050–1055. doi: 10.1056/NEJM198704233161703. [DOI] [PubMed] [Google Scholar]
  8. Maury C. P., Teppo A. M. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Clin Nephrol. 1984 Dec;22(6):284–292. [PubMed] [Google Scholar]
  9. Maury C. P., Teppo A. M., Höckerstedt K. Acute phase proteins and liver allograft rejection. Liver. 1988 Apr;8(2):75–79. doi: 10.1111/j.1600-0676.1988.tb00971.x. [DOI] [PubMed] [Google Scholar]
  10. Meliconi R., Uguccioni M., Lalli E., Nesci S., Delfini C., Paradisi O., Lucarelli G., Gasbarrini G., Facchini A. Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation. J Clin Pathol. 1992 Jan;45(1):61–65. doi: 10.1136/jcp.45.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mitchell T. I., Coon C. I., Brinckerhoff C. E. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest. 1991 Apr;87(4):1177–1185. doi: 10.1172/JCI115116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Neri A., Callea V., D'Ascola D. G., Martino B. Immune status in thalassemia major. Haematologica. 1986 Nov-Dec;71(6):511–516. [PubMed] [Google Scholar]
  13. Ramadori G., Sipe J. D., Colten H. R. Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol. 1985 Dec;135(6):3645–3647. [PubMed] [Google Scholar]
  14. Rowe I. F., Worsley A. M., Donnelly P., Catovsky D., Goldman J. M., Galton D., Pepys M. B. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia. J Clin Pathol. 1984 Mar;37(3):263–266. doi: 10.1136/jcp.37.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shainkin-Kestenbaum R., Berlyne G., Zimlichman S., Sorin H. R., Nyska M., Danon A. Acute phase protein, serum amyloid A, inhibits IL-1- and TNF-induced fever and hypothalamic PGE2 in mice. Scand J Immunol. 1991 Aug;34(2):179–183. doi: 10.1111/j.1365-3083.1991.tb01535.x. [DOI] [PubMed] [Google Scholar]
  16. Thomas E. D., Storb R., Clift R. A., Fefer A., Johnson L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895–902. doi: 10.1056/NEJM197504242921706. [DOI] [PubMed] [Google Scholar]
  17. Vogel S. N., Sipe J. D. The role of macrophages in the acute phase SAA response to endotoxin. Surv Immunol Res. 1982;1(3):235–241. doi: 10.1007/BF02918462. [DOI] [PubMed] [Google Scholar]
  18. Walker S. A., Riches P. G., Rogers T. R., White S., Hobbs J. R. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period. J Clin Pathol. 1984 Sep;37(9):1022–1026. doi: 10.1136/jcp.37.9.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Walker S. A., Rogers T. R., Riches P. G., White S., Hobbs J. R. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period. J Clin Pathol. 1984 Sep;37(9):1018–1021. doi: 10.1136/jcp.37.9.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zuckerman S. H., Surprenant Y. M. Simplified microELISA for the quantitation of murine serum amyloid A protein. J Immunol Methods. 1986 Aug 21;92(1):37–43. doi: 10.1016/0022-1759(86)90501-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES